CNS Therapeutics Receives $50,000 New Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=161f8c99-83e7-4361-8540-0678bb180c5f&Preview=1
Date 4/28/2011
Company Name CNS Therapeutics
Mailing Address 332 Minnesota Street Saint Paul, MN 55101
Company Description CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.